Antimicrobial Resistance

Debate between Greg Clark and Maria Caulfield

Wednesday 17th April 2024 Westminster Hall

[Maria Caulfield]

The hon. Gentleman is absolutely right. I will touch on how much more we can do with screening to prevent some infections. This cannot just be about developing new antibiotics; it is about preventing infections and screening for them in a range of scenarios.

To touch on some of the high prevalence internationally, 89% of all antimicrobial resistance deaths occur in Africa and Asia, so we have responsibility to ensure that we help out in those countries that struggle most with the issue. We must continue to ensure that people around the world have access to the antibiotics they need, which is why the £40 million in innovative research through the global AMR innovation fund that my hon. Friend the Member for Colchester mentioned is so crucial. It enabled the development of a new antibiotic for drug-resistant gonorrhoea, the first in 30 years.

The hon. Member for Tiverton and Honiton (Richard Foord) touched on the role of water, which requires an international effort. Sanitation is often a leading cause of infection in other countries. That is why we are working hard with other countries and the WHO to improve water sanitation and hygiene to reduce infections occurring in the first place.

In 2022, we made a further £210 million commitment for the second phase of the Fleming Fund to strengthen our surveillance systems. As the hon. Member for Strangford (Jim Shannon) said, it is not just about treatment, but about picking up infections and trends and trying to prevent them in the first place. The Fleming Fund is having an impact. Since 2015, over 240 laboratories have been upgraded with state-of-the-art equipment, training and new systems, and over 75 national action plans on AMR have been developed in Africa and Asia to try to get the death toll from antibiotic resistance down. The Fleming Fund leverages UK expertise, with over 3,000 healthcare workers being trained in antimicrobial surveillance principles through a partnership with the NHS.

Looking ahead, we recognise the risks. We are not being complacent either domestically or internationally. Through the hard work of my hon. Friend the Member for Colchester, we have put some good building blocks in place, but we need to look to the future. Our next five-year antimicrobial resistance national action plan will be published later this year.

[Greg Clark]

I am grateful to the Minister for what she said about phages. She knows that UK science is world-leading, especially in this area. In Imperial College alone, there are 180 researchers working on AMR. One such researcher, Professor Jonathan Cook, has noted the real benefits of point-of-care testing and the fact that other countries, including the Netherlands, have managed to make a big impact. Can the Minister say whether we have plans to accelerate the availability of such testing in this country?

[Maria Caulfield]

My right hon. Friend makes a good point, which I will take away and follow up on. There are some really good examples in primary care where some testing is done. Primary care nurses particularly will do point-of-care testing to see whether someone’s infection will be sensitive to antibiotics or not. I believe there is more we can do in that space, both in primary and secondary care, so I am happy to write to him about how we can roll that out nationally. Importantly, that testing helps to maintain patients’ expectations. I cannot remember who, but someone said that people go along to GPs and expect to be given antibiotics. Point-of-care testing will be able to reassure them that they either do or do not need antibiotics and tell them which type is best suited to their type of infection. That is crucial.

Our plan will set out an ambitious programme of work, learning from covid-19 in testing, surveillance and treatment to prepare for infections of the future. I can reassure my hon. Friend the Member for Colchester that we will continue to collaborate internationally with organisations such as the WHO and use our soft power to help to support in particular African and Asian nations, which are suffering greatly from the mortality of antimicrobial resistance. This is a hidden pandemic that will have consequences for us all if we do not deal with it.

Question put and agreed to.

Sickle Cell Treatment

Debate between Greg Clark and Maria Caulfield

Wednesday 8th December 2021 Westminster Hall

[Maria Caulfield]

The hon. Member makes an excellent point. There are NICE guidelines on sickle cell, so I will ask departmental colleagues to look at how often they are not followed. The issue was raised about analgesia not being given within half an hour of someone presenting. That is in NICE guidance, and the guideline should be followed in A&E or other areas where patients are admitted. I am happy to look at the prevalence of that not happening and why not. Again, I think that a lot of it is not deliberate. Much of it is to do with the education of staff, who might be in busy A&E departments with lots of people in pain, and they might not realise the impact on a sickle cell patient who does not get analgesia in a timely manner.

[Greg Clark]

On the point about A&E, I welcome, as I am sure colleagues do, the commitment to look at the figures. Given that we have APPG reports, could the Minister perhaps circulate them, through the NHS, to A&E departments to remind them of the current NICE guidance?

[Maria Caulfield]

My right hon. Friend makes an excellent point. I am happy to work with departmental officials to look at how, if the NICE guidelines are there, we can make sure they are distributed so that all clinical areas are aware of them, particularly, as the point was made, to areas where there is a high prevalence of sickle cell that are more likely to see someone admitted to A&E. I am happy to take that forward.

I want to reassure colleagues that progress is being made. I want to place on the record my thanks to all those in specialist units who work really hard behind the scenes to improve the care for sickle cell patients and to get information out to the NHS across the board. Where there are gaps, I am happy to work with the APPG to make sure we address those.

Oral Answers to Questions

Debate between Greg Clark and Maria Caulfield

Tuesday 19th March 2019 Commons Chamber

[Greg Clark]

Substantial analysis has shown that, of all the options available, the Prime Minister’s deal is the one that provides the best economic future, and I hope the hon. Lady will support it.

[Maria Caulfield (Lewes) (Con)]

Post offices are at the heart of our communities, so does the Minister welcome the news that Newick post office in my constituency, after being closed for months following the sad death of the postmaster, Terry, is set to reopen? Does she agree that we must do all we can to keep post offices open in our rural communities?

Oral Answers to Questions

Debate between Greg Clark and Maria Caulfield

Tuesday 30th January 2018 Commons Chamber

[Greg Clark]

Officials are meeting their counterparts in the Welsh Government so that they can understand and explore the proposal that has been made.

[Maria Caulfield (Lewes) (Con)]

T7. As banks are closing on our high streets, two of my towns, Newhaven and Polegate, are not having any banking facilities left. Will the Minister consider expanding the facilities that post offices offer? Postmasters such as the one in East Dean in my constituency are keen to do more, but Post Office Ltd refuses to allow them to do so.

Bombardier

Debate between Greg Clark and Maria Caulfield

Tuesday 10th October 2017 Commons Chamber

[Greg Clark]

I am grateful for the support of the hon. Gentleman. The more we can be absolutely clear that the whole United Kingdom, all parties and both sides of the House share this view that the complaint should be withdrawn and the dispute settled, the better, and that has been emphatically the case here. Again, I make the point that it is clearly in all our interests to have free trade. In a sector where 90% of products are exported, that is obviously the case. But that trade needs to happen in a way that gives us confidence that disputes, which will happen from time to time, are resolved in a fair and objective way. We play by the rules—we always will—and all we want is a system that respects that. We are confident that we will gain from that scrutiny.

[Maria Caulfield (Lewes) (Con)]

Will the Government consider stepping in to support the workers in Northern Ireland who are affected by Boeing’s decision in the same way as they stepped in to support the workers during the Tata Steel dispute?

[Greg Clark]

We will of course always be behind the workers in every part of the country, but my determination is not only to save those jobs in Northern Ireland but to see the number of jobs increase and the company prosper and grow. As has been said, the C Series is gaining orders—it is an aircraft that fills an important position in the market. I would like to see the Belfast success story continue to grow in the years ahead.

Oral Answers to Questions

Debate between Greg Clark and Maria Caulfield

Monday 21st March 2016 Commons Chamber

[Greg Clark]

As the hon. Gentleman knows, we have a consultation on this. I do not know whether he has contributed to it, but it has now closed. We are reflecting on the responses, and I will update the House when we have had a chance to do that.

[Maria Caulfield (Lewes) (Con)]

T2. Many towns and villages in my constituency have formally adopted their neighbourhood plans. Places such as Newick and Ringmer have had their plans in place for a long time, yet they are constantly challenged by developers who put in applications for sites outside the plan. Will the Minister uphold the status of neighbourhood plans in the planning process and return local democracy to our villages and towns?

Local Government Finance

Debate between Greg Clark and Maria Caulfield

Thursday 17th December 2015 Commons Chamber

[Greg Clark]

The hon. Gentleman will know more than most that simply looking at central Government grant in an age in which local councils, at their own request and following their own campaign, are increasingly in charge of their own resources, is not the right way to consider the issue. We should look at the total resources available, including the business rate revenues, in respect of which Nottingham and Nottinghamshire authorities are doing very well, rightly attracting more businesses and expanding businesses. That is a buoyant source of income for his city and his county.

[Maria Caulfield (Lewes) (Con)]

As my hon. Friend the Member for Wealden (Nusrat Ghani) said, we met local councils yesterday and we were told that the counties of East Sussex, West Sussex and Surrey are joining together for a devolution bid, called “The three southern counties” bid. Currently the area’s contribution to the Exchequer’s revenue is second only to that of the City of London. Can the Secretary of State inform us what influence, if any, devolution bids such as “The three southern counties” bid will have on today’s funding settlement?

[Greg Clark]

I am grateful to my hon. Friend for her question, and I look forward to the discussions with the council leaders about the devolution deal. Today’s settlement does not include the effects of those deals. One proposal that we will consider is for the earlier retention of business rates. I am delighted that such imaginative proposals have been put forward locally.